Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endocrine Responsive Early Breast Cancer”

6 trials

Showing 6 of 6 results

Not applicableUnknownNCT02166281
What this trial is testing

Impact of Adjuvant Treatment With Aromatase Inhibitor on Sleep Disturbances in Postmenopausal Women With Endocrine Responsive Early Breast Cancer

Who this might be right for
Endocrine Responsive Early Breast Cancer
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 200
Large-scale testing (Phase 3)UnknownNCT00412022
What this trial is testing

HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.

Who this might be right for
Breast Cancer
National Cancer Institute, Naples 1,294
Large-scale testing (Phase 3)Active Not RecruitingNCT02918084
What this trial is testing

CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer

Who this might be right for
Breast Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 1,000
Not applicableActive Not RecruitingNCT02308085
What this trial is testing

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

Who this might be right for
Early Breast Cancer
ETOP IBCSG Partners Foundation 518
Not applicableStudy completedNCT00784888
What this trial is testing

Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy

Who this might be right for
Breast Neoplasms
Pfizer 344
Not applicableLooking for participantsNCT07084558
What this trial is testing

ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness

Who this might be right for
Early and Locally Advanced Breast Cancer
Austrian Breast & Colorectal Cancer Study Group 350

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation